Get the app
US › Healthcare

Immuron Ltd ADR (IMRN)

US · Healthcare · Biotechnology

$0.98-4.66%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$3.6M
Revenue YoY
-10.4%
Net profit
$-1.9M
Net margin
-54.4%

Key statistics

Market cap
$7.9M
Forward P/E
0.0
P/B
1.21
Book value
$0.97
EPS (TTM)
$-0.34
52-week high
$2.35
52-week low
$0.68
50-day MA
$1.19
200-day MA
$1.01
Beta
0.47

Analyst view

with an average price target of $3.88.

Shareholding

Institutions
0.97%

Largest institutional holders

FundStake
Citadel Advisors Llc0.53%
HRT FINANCIAL LLC0.26%
Rhumbline Advisers0.09%
BNP Paribas Arbitrage, SA0.06%
Morgan Stanley - Brokerage Accounts0.02%
UBS Group AG0.00%
BlackRock Inc0.00%
Jane Street Group LLC0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Immuron Ltd ADR — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-19.